Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Kit for quantitatively determining NGAL (neutrophil gelatinase-associated lipocalin) in urine or blood

A quantitative detection and kit technology, applied in the field of biomedicine, can solve the problems of high consumption of kits, high cost, and inability to freely replace reagent units, so as to improve detection sensitivity, easy to use and operate, and meet the needs of clinical testing.

Inactive Publication Date: 2018-02-02
SHANDONG ZHUSHITANG MEDICAL TREATMENT INSTR CO LTD
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, the existing kits generally have two reagent units and the box body as an integrated structure. The integrated structure has good stability, but it cannot freely replace the reagent units (reagent bottles), which makes the kit consume a lot of money and cost.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for quantitatively determining NGAL (neutrophil gelatinase-associated lipocalin) in urine or blood
  • Kit for quantitatively determining NGAL (neutrophil gelatinase-associated lipocalin) in urine or blood

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] as attached figure 1 , 2 As shown, in this embodiment, the kit for quantitatively detecting NGAL in urine or blood includes a box cover 1, a box body 2, and a first reagent unit 3-1 and a second reagent unit 3-2 placed in the box body, Both the first reagent unit and the second reagent unit are composed of a bottle cap 5 and a bottle body 6, the outside of the first reagent unit and the second reagent unit are independent of each other, and the first reagent unit and the second reagent unit are connected by a ring-shaped external bracket 7 The surroundings of the two reagent units connected by brackets are filled with foam plastics or sponges and other fixtures. The reagents contained in the first reagent unit include phosphate buffer 0.1mol / L, PH7.5, Triton X-100 0.1g / 100ml , polyethylene glycol 6000 1g / 100ml, sodium azide 0.05g / 100ml, the reagent contained in the second reagent unit contains 0.1g / 100ml of latex particles modified by mouse anti-human NGAL monoclonal a...

Embodiment 2

[0021] The difference between this example and Example 1 is that the reagent contained in the first reagent unit contains phosphate buffer 0.05mol / L, pH7.5, Triton X-100 0.1g / 100ml, polyethylene glycol 6000 1g / 100ml, sodium azide 0.1g / 100ml. At the same time, the reagents contained in the second reagent unit include 0.1g / 100ml of latex particles modified by mouse anti-human NGAL monoclonal antibody, 0.25g / 100ml of latex particles modified by goat anti-human NGAL polyclonal antibody, 0.05g / 100ml of casein, Sodium nitrogen 0.05g / 100ml.

[0022] The reagent was evaluated on an automatic biochemical analyzer, and the results showed that the minimum detection limit was 12ng / ml, and the linear range was 20ng / ml~4000ng / ml.

Embodiment 3

[0024] In this embodiment, the reagent contained in the first reagent unit contains phosphate buffer 0.1mol / L, pH7.5, Triton X-100 0.2g / 100ml, polyethylene glycol 6000 1g / 100ml, sodium azide 0.05 g / 100ml. At the same time, the reagents contained in the second reagent unit include 0.15g / 100ml of latex particles modified by mouse anti-human NGAL monoclonal antibody, 0.25g / 100ml of latex particles modified by goat anti-human NGAL polyclonal antibody, 0.05g / 100ml of casein, Sodium nitrogen 0.05g / 100ml.

[0025] The reagent was evaluated on an automatic biochemical analyzer, and the results showed that the minimum detection limit was 8ng / ml, and the linear range was 20ng / ml~4000ng / ml.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a kit for quantitatively determining the NGAL (neutrophil gelatinase-associated lipocalin) in urine or blood. The kit comprises a kit cover, a kit body, a first reagent unit and a second reagent unit, wherein the first reagent unit and the second reagent unit are arranged in the kit body; the outside of the first reagent unit and the outside of the second reagent unit aremutually independent; the first reagent unit and the second reagent unit are connected through a support frame; fixing articles are filled around the two reagent units connected through the support frame; reagents contained by the first reagent unit include phosphate buffer solution, triton, polyethylene glycol and sodium azide; reagents contained by the second reagent unit include mouse anti-human NGAL monoclonal antibody modified latex particles, goat anti-human NGAL polyclonal antibody modified latex particles, casein and sodium azide. The kit has the advantages that the use and the operation are simple and convenient; the NGAL in the urine or blood can be fast, accurately and quantitatively determined; the detection sensitivity is improved; the linear measurement range is increased; the clinical detection requirements are fully met.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a kit for quantitatively detecting NGAL in urine or blood. The kit is a testing kit suitable for use in a fully automatic biochemical analyzer and can be used for clinical auxiliary diagnosis. Background technique [0002] Up to 50% of patients in the intensive care unit may have some degree of acute renal failure. The mortality rate of acute renal failure is at the forefront of the mortality rate of critical illness. Prediction of acute renal failure has not improved significantly over the past 40 years. At present, the most commonly used biological indicator for clinical judgment of human kidney injury is the concentration of serum creatinine, but the concentration of serum creatinine can only be detected after a certain degree of kidney injury, and serum creatinine is not an ideal indicator for early diagnosis. Although the relatively new biological index serum cystatin C that has...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/92
CPCG01N33/92G01N2800/347
Inventor 朱坤福朱晓肸薛飞
Owner SHANDONG ZHUSHITANG MEDICAL TREATMENT INSTR CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products